Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2 - and TET2 -Mutant Acute Myeloid Leukemia

Published 2017 View Full Article

Authors

Keywords

Journal

Cancer Discovery

Volume 7, Issue 5, Pages 494-505

Publisher

American Association for Cancer Research (AACR)

Online

2017-02-14

DOI

10.1158/2159-8290.cd-16-1049

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Cancer Discovery

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Become a Peeref-certified reviewer